100µg Industrial Grade Plasmid Prep
Antibody Gene Service
Starting at
$189/plasmid
Order Now
Request Now
-Minimum 5 plasmids/order
-Terms and conditions apply
-Terms and conditions apply
Service breakdown
| Length | Starting Turnaround Time (BD) | Deliverable | Price/100 µg plasmid |
|---|---|---|---|
| ≤500 bp | 8 - 13 | 100 µg Industrial Grade Plasmid |
$239 |
| 13 - 18 | $189 | ||
| 501–700 bp | 8 - 13 | $269 | |
| 13 - 18 | $209 |
Seamless Delivery Of Your
Candidate Genes
In Your Selected
Expression Vector
Gene Synthesis
Subcloning
Plasmid Preparation
Terms and conditions:
- $189/plasmid must be ordered through Economy Gene Synthesis (SC1645)
- $239/plasmid must be ordered through Standard Gene Synthesis (SC1010)
- 100µg Industrial Grade Plasmid Prep (SC1844) must be bundled to be eligible for the promotion
- Minimal 5 bundled gene synthesis & plasmids are required for this promotion.
- Promotion cannot be combined with other discounts, coupons, or any pre-arranged pricing agreements.
- Turnaround time might be extended for difficult genes. Gene manufacturing simplicity is a combination of GC% & repetitive sequences and is determined by GenScript during quotation process.
- Promotion is valid from 4/13/2022 to 6/12/2022.
- More>>
- Industrial Grade Specs can be found at Plasmid Preparation Services
- Promotion doesn't apply to China, Asia Pacific, United Kingdom, Latin Europe and Africa
- Turnaround time is calculated as the total time, in business days, spent from order confirmation to order shipment. Turnaround time is not guaranteed
-
Industry Leading Codon Optimization
-
150+ IP Free Vectors and vector storage options
-
100% Sequence Accuracy Guaranteed
-
Highly Scalable and Customizable downstream solutions
Antibody drug discovery and development identifies new therapeutic antibodies to combat different diseases such as cancers, HIV, autoimmune and more. It can broadly be divided into six stages:
1
Target Identification
& Validation
Molecular targets are
identified
using
a combination of different approaches
to fully characterize and validate the
antibody-antigen binding mechanism.
2
Antibody Lead
Generation
In this discovery phase,
validated
molecular targets are used as
antigens to initiate an immune
response in a host animal to generate
therapeutic antibody candidates.
3
Antibody Lead
Optimization
This final stage of
therapeutic
antibody discovery sees the
modification of drug candidates to
increase its effectiveness, affinity and
to diminish immunogenicity. It's also
the stage where rodent monoclonal
antibodies are converted to their
humanized forms.
4
Antibody Lead
& Functionality
Analysis
In vitro and in
vivo
testing
are
done to
further evaluate potential drug
candidates to check their feasibility
and efficiency.
5
Antibody Production
& Preclinical
Development
This is the final stage of
preclinical
development, where final antibody
drug candidate selection and
recombinant expression takes place.
6
Preclinical
Research
Preclinical development and
testing
is
the phase of therapeutic antibody
discovery and development where the
safety of the lead is checked before
clinical trials.
When it comes to antibody drug discovery, it may mean differently to different groups of researchers, but they all include rational design and/or directed evolution to achieve some enhanced properties of proteins and antibodies (such as the binding affinity, stability, etc.).
Find out how outsourcing to GenScript, the industry leading CRO, will facilitate your antibody and protein engineering projects with custom gene synthesis, plasmid prep services, precision mutant libraries, high throughput gene to antibody expression, and much more.
Latest Antibody Drug Discovery News
Antibody Drug Discovery Solutions Made Easy
Gene Synthesis, Plasmid prep and cloning
services
High-Throughput Gene to Antibody Production
Mutation and Library services
Protein and antibody production
Highly customizable gene, cloning and plasmid prep solutions for therapeutic target expression engineering.
Our most cost effective option for small-scale recombinant antibodies. This popular service combines GenScript's expertise in high-throughput gene synthesis with a proprietary transient antibody expression technology to produce high quality recombinant antibodies for both therapeutic antibody drug candidates and reagent antibodies.
Comprehensive mutation and library services for all your specific screening needs.
A wide range of expression systems to deliver tailor-made products of the highest quality.
